IBM Retirement Fund decreased its stake in shares of PerkinElmer, Inc. (NYSE:PKI) by 6.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,236 shares of the company’s stock after selling 731 shares during the period. IBM Retirement Fund’s holdings in PerkinElmer were worth $574,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the stock. Riverhead Capital Management LLC increased its stake in shares of PerkinElmer by 1,298.8% in the second quarter. Riverhead Capital Management LLC now owns 545,600 shares of the company’s stock valued at $7,998,000 after buying an additional 506,594 shares during the period. Vanguard Group Inc. increased its stake in PerkinElmer by 5.2% in the second quarter. Vanguard Group Inc. now owns 9,959,777 shares of the company’s stock worth $522,092,000 after buying an additional 494,551 shares during the last quarter. Thrivent Financial for Lutherans increased its stake in PerkinElmer by 132.5% in the second quarter. Thrivent Financial for Lutherans now owns 648,650 shares of the company’s stock worth $34,002,000 after buying an additional 369,700 shares during the last quarter. Calvert Investment Management Inc. increased its stake in PerkinElmer by 2,232.4% in the second quarter. Calvert Investment Management Inc. now owns 148,014 shares of the company’s stock worth $7,759,000 after buying an additional 141,668 shares during the last quarter. Finally, Bank of Montreal Can purchased a new stake in PerkinElmer during the second quarter worth about $7,381,000. 89.52% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for PerkinElmer (NYSE:PKI)

PerkinElmer, Inc. (NYSE:PKI) traded up 1.77% during trading on Friday, reaching $53.90. The company had a trading volume of 778,571 shares. The firm has a market capitalization of $5.90 billion, a price-to-earnings ratio of 25.09 and a beta of 0.90. The company’s 50-day moving average is $52.67 and its 200 day moving average is $53.37. PerkinElmer, Inc. has a 52 week low of $39.50 and a 52 week high of $57.28.

PerkinElmer (NYSE:PKI) last posted its earnings results on Monday, November 7th. The company reported $0.68 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.66 by $0.02. PerkinElmer had a net margin of 10.48% and a return on equity of 14.55%. The firm earned $548 million during the quarter, compared to the consensus estimate of $572.03 million. During the same quarter last year, the firm earned $0.60 EPS. The firm’s revenue for the quarter was down 2.7% on a year-over-year basis. Equities analysts anticipate that PerkinElmer, Inc. will post $2.77 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, February 10th. Investors of record on Friday, January 20th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Wednesday, January 18th. This represents a $0.28 annualized dividend and a yield of 0.52%. PerkinElmer’s dividend payout ratio (DPR) is presently 13.02%.

WARNING: This piece was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this piece can be accessed at http://www.watchlistnews.com/perkinelmer-inc-pki-position-reduced-by-ibm-retirement-fund/1060878.html.

A number of research firms have issued reports on PKI. Zacks Investment Research raised PerkinElmer from a “hold” rating to a “buy” rating and set a $62.00 price objective on the stock in a research note on Tuesday, October 4th. Cantor Fitzgerald set a $60.00 price objective on PerkinElmer and gave the stock a “buy” rating in a research note on Sunday, December 25th. Finally, Barclays PLC reaffirmed a “sell” rating and issued a $50.00 price objective on shares of PerkinElmer in a research note on Tuesday, November 8th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and four have assigned a buy rating to the company. The company has an average rating of “Hold” and an average price target of $55.20.

In related news, Director Alexis P. Michas sold 15,000 shares of PerkinElmer stock in a transaction that occurred on Thursday, December 1st. The shares were sold at an average price of $51.00, for a total value of $765,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 2.30% of the stock is currently owned by corporate insiders.

PerkinElmer Company Profile

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental and laboratory markets. The Company’s operating segments include Human Health, Environmental Health and Corporate. The Human Health segment concentrates on developing diagnostics, tools and applications to help detect diseases earlier.

5 Day Chart for NYSE:PKI

Want to see what other hedge funds are holding PKI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PerkinElmer, Inc. (NYSE:PKI).

Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.